ImmunoPrecise Antibodies ... (IPA)
NASDAQ: IPA
· Real-Time Price · USD
3.20
0.57 (21.67%)
At close: Aug 22, 2025, 3:59 PM
2.69
2.27%
Pre-market: Aug 22, 2025, 09:26 AM EDT
ImmunoPrecise Antibodies Income Statement
Financials in CAD. Fiscal
year is
May - April.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Aug 9, 2023 | Apr 30, 2023 | Jan 31, 2023 | Dec 13, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 |
Revenue | 6.98M | 6.15M | 6.13M | 5.26M | 6.46M | 6.22M | 6.15M | 5.69M | 5.62M | 5.17M | 5.18M | 4.69M | 5.24M | 4.82M | 4.72M | 4.59M | 4.88M | 4.52M | 4.75M | 3.77M |
Cost of Revenue | 2.52M | 2.86M | 2.69M | 2.91M | 3.35M | 3.02M | 3.2M | 2.89M | 2.28M | 2.21M | 2.4M | 2.21M | 1.92M | 2.23M | 2.15M | 2.08M | 2.1M | 953.85K | 1.97M | 1.35M |
Gross Profit | 4.46M | 3.29M | 3.44M | 2.36M | 3.11M | 3.2M | 2.95M | 2.79M | 3.34M | 2.96M | 2.78M | 2.48M | 3.32M | 2.59M | 2.58M | 2.51M | 2.78M | 3.56M | 2.79M | 2.41M |
Operating Income | -1.46M | -3.29M | -2.82M | -4.63M | -3.52M | -3.34M | -2.31M | -3.16M | -3.62M | -4.52M | -6.87M | -9.8M | -4.16M | -4.27M | -4.67M | -3.38M | -2.47M | -954K | -660K | -43K |
Interest Income | n/a | n/a | n/a | n/a | n/a | 3K | 10K | 8K | 197K | 39K | 36K | n/a | 109K | 160K | 6K | 4K | n/a | 12K | 515.66K | n/a |
Pretax Income | -1.9M | -24.54M | -3.06M | -4.78M | -18.82M | -3.46M | -2.59M | -3.83M | -5.9M | -4.59M | -7.48M | -9.78M | -4.37M | -3.62M | -4.82M | -3.04M | -4.01M | -1.21M | -410K | -368K |
Net Income | -2.16M | -21.52M | -2.55M | -4M | -18.05M | -2.68M | -2.41M | -3.42M | -5.13M | -4.7M | -7.35M | -9.38M | -4.64M | -3.83M | -5.01M | -3.23M | -5.03M | -1.29M | -464K | -549K |
Selling & General & Admin | 4.74M | 4.9M | 4.51M | 4.65M | 5.03M | 4.83M | 4.23M | 5.05M | 7.6M | 4.95M | 4.65M | 5.25M | 5.84M | 4.17M | 3.71M | 4.04M | 4.53M | 3.88M | 2.91M | 2.02M |
Research & Development | 1.09M | 1.06M | 1.16M | 1.64M | 927K | 1M | 1.04M | 947K | 919K | 1.56M | 5M | 6.18M | 1.33M | 2.06M | 3.04M | 1.12M | 615.47K | n/a | 1.05M | 309.21K |
Other Expenses | 90K | 627K | 591K | 460K | 669K | 709K | -2.11M | -3.2M | -4.76M | -3.55M | -6.87M | -8.96M | 697K | -3.81M | -4.18M | -2.63M | 99.68K | -304K | -1.16M | 101K |
Operating Expenses | 5.92M | 6.59M | 6.26M | 7.13M | 6.62M | 6.54M | 2.95M | 2.79M | 3.34M | 2.96M | 2.78M | 2.48M | 3.32M | 2.59M | 2.58M | 2.51M | 2.78M | 3.56M | 2.79M | 2.41M |
Interest Expense | n/a | 172K | 120K | 2K | 355K | 5K | 5K | 5K | 27K | n/a | n/a | 5K | 96K | 21K | 20K | 103K | 177.88K | 169.07K | 245.1K | 240K |
Selling & Marketing Expenses | 1.03M | 1.31M | 1.24M | 718K | 909K | 649K | 921K | 1.06M | 934K | 836K | 817K | 1.02M | 151K | 228K | 576K | 163K | 186.19K | 215.9K | 255.6K | 33.31K |
Cost & Expenses | 8.44M | 9.44M | 8.94M | 10.04M | 9.97M | 9.56M | 8.46M | 5.69M | 11.67M | 8.72M | 12.05M | 13.65M | 8.06M | 8.62M | 8.91M | 7.28M | 7.16M | 5.47M | 5.42M | 3.86M |
Income Tax Expense | 261K | -3.01M | -506K | -776K | -777K | -517K | -182K | -415K | -767K | 104K | -126K | -403K | 275K | 208K | 190K | 188K | 1.02M | 89.46K | 54K | 181.01K |
Shares Outstanding (Basic) | 33.12M | 32.85M | 28.13M | 27.13M | 26.95M | 25.8M | 25.05M | 24.74M | 25.03M | 24.95M | 24.87M | 24.74M | 20.76M | 19.43M | 19.34M | 19.22M | 16.87M | 16.9M | 15.65M | 14.48M |
Shares Outstanding (Diluted) | 33.12M | 32.85M | 28.13M | 27.13M | 26.95M | 25.8M | 25.05M | 24.74M | 25.03M | 24.95M | 24.87M | 24.74M | 20.76M | 19.43M | 19.34M | 19.22M | 16.9M | 16.9M | 15.65M | 14.48M |
EPS (Basic) | -0.07 | -0.66 | -0.09 | -0.15 | -0.67 | -0.1 | -0.1 | -0.14 | -0.2 | -0.19 | -0.3 | -0.38 | -0.22 | -0.2 | -0.26 | -0.17 | -0.3 | -0.08 | -0.03 | -0.04 |
EPS (Diluted) | -0.07 | -0.66 | -0.09 | -0.15 | -0.67 | -0.1 | -0.1 | -0.14 | -0.2 | -0.19 | -0.3 | -0.38 | -0.22 | -0.2 | -0.26 | -0.17 | -0.3 | -0.08 | -0.03 | -0.04 |
EBITDA | -988K | -22.97M | -1.52M | -3.38M | -2.27M | -2.14M | -1.44M | -2.27M | -3.89M | -2.89M | -6.01M | -8.23M | -3.12M | -2.65M | -3.86M | -1.98M | -2.94M | -100K | 809K | 784K |
EBIT | -1.9M | -24.36M | -2.94M | -4.77M | -18.82M | -3.45M | -2.59M | -3.77M | -5.87M | -4.59M | -7.48M | -9.78M | -4.27M | -3.6M | -4.8M | -2.94M | -3.83M | -1.04M | -165K | -128K |
Depreciation & Amortization | 913K | 1.4M | 1.41M | 1.4M | 1.58M | 1.31M | 1.35M | 1.49M | 1.98M | 1.69M | 1.46M | 1.55M | 926K | 949K | 937K | 957K | 891.15K | 936.19K | 973.74K | 911.92K |